Search

Your search keyword '"DELFORGE, A."' showing total 6,323 results

Search Constraints

Start Over You searched for: Author "DELFORGE, A." Remove constraint Author: "DELFORGE, A."
6,323 results on '"DELFORGE, A."'

Search Results

1. LocoMMotion: a study of real-life current standards of care in triple-class exposed patients with relapsed/refractory multiple myeloma – 2-year follow-up (final analysis)

5. Discrimination of primary and chronic cytomegalovirus infection based on humoral immune profiles in pregnancy

6. NSAID exposure delays time-to-pregnancy in patients with spondyloarthritis: an analysis of the GR2 prospective cohort

7. Belantamab mafodotin monotherapy for relapsed or refractory multiple myeloma: a real-world observational study in the United States

8. Efficient and rapid one-step method to generate gene deletions in Streptococcus pyogenes

9. Collaborative Skills in Language Courses: How to Support Pupils?

10. Seroprevalence and placental transfer of SARS-CoV-2 antibodies in unvaccinated pregnant women

12. Préface

14. Caffeine consumption outcomes on amyotrophic lateral sclerosis disease progression and cognition

15. The novel family of Warbicin® compounds inhibits glucose uptake both in yeast and human cells and restrains cancer cell proliferation

16. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

17. Ide-cel vs standard regimens in triple-class–exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analyses

18. Comparative Effectiveness of Teclistamab Versus Real-World Physician’s Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma

19. Nosocomial Transmission of Necrotizing Fasciitis: A Molecular Characterization of Group A Streptococcal DNases in Clinical Virulence

20. Teclistamab in Relapsed or Refractory Multiple Myeloma

21. Caffeine consumption outcomes on amyotrophic lateral sclerosis disease progression and cognition

22. Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial

23. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

29. Health-related quality of life with idecabtagene vicleucel in relapsed and refractory multiple myeloma

30. MALL Tools Tried and Tested

31. Learning to Design a Mobile Hunt on Actionbound: A Complex Task?

32. Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens: patient-reported outcomes from the phase 3, randomised, open-label KarMMa-3 clinical trial

33. Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma: Results From the Phase II MajesTEC-1 Study

34. Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)

35. Comparative Efficacy of Teclistamab Versus Current Treatments in Real-World Clinical Practice in the Prospective LocoMMotion Study in Patients with Triple-Class-Exposed Relapsed and/or Refractory Multiple Myeloma

37. Belantamab mafodotin: an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myeloma

38. A Characterization of Women Living with HIV in Belgium

39. Health-Related Quality of Life in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: Findings From the Phase III MAIA Trial.

40. Phase I Study of Safety and Pharmacokinetics of RO7297089, an Anti-BCMA/CD16a Bispecific Antibody, in Patients with Relapsed, Refractory Multiple Myeloma

42. Accuracy of the Infectious Diseases Society of America and British Thoracic Society Criteria for Acute Pneumonia in Differentiating Chemical and Bacterial Complications of Aspiration in Comatose Ventilated Patients Following Drug Poisoning

43. Management of erythropoietic protoporphyria with cholestatic liver disease: A case report

44. Small myeloid subclones are present at diagnosis of multiple myeloma in patients who develop secondary myelodysplastic syndromes

45. Phase I Study of Safety and Pharmacokinetics of RO7297089, an Anti-BCMA/CD16a Bispecific Antibody, in Patients with Relapsed, Refractory Multiple Myeloma

46. Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study

50. Préface

Catalog

Books, media, physical & digital resources